Claims over human genome editing: scientific irresponsibility at its worst

By Sarah Chan This post first appeared in The Motley Coat on 26 November 2018. The announcement made today, that the world’s first genome-edited babies have been born in China, is of grave ethical concern. In evaluating this news, we should first remember that these claims have not yet been scientifically validated through peer reviewed publication […]

Read More…

Not long for this world: The timing of requests for a medically hastened death in the context of end of life care

By Lori Seller and Veronique Fraser As ethicists working in university health centers, many of our consultations revolve around decision making at the end of life. We know from academic literature, as well as from experience, that end of life discussions tend to come late in the illness trajectory and that the quality of these discussions […]

Read More…

JOB: Postdoctoral Research Fellow in Bioethics & Public Policy, King’s College London

An opportunity to do postdoctoral research at King’s College London focused on applied philosophy and healthcare. Post details: This post is for a Postdoctoral Researcher to work on a Wellcome-funded project entitled, “’But why is that better?’: An investigation of what applied philosophy and ethics can bring to quality improvement work in health care”. The post will […]

Read More…

Obesity, equity and choice

By T.M. Wilkinson An awful lot of people are getting fatter than is good for their health. Many jurisdictions, under pressure from public health advocates, are trying to steer choices away from the obesogenic by taxing and regulating sugary and fatty food and drink. No one I know of thinks these methods will solve the […]

Read More…

Sculpting body parts: How the arts contribute to ethical reflection

By Sarah N Boers Recent advances in stem cell technology enable the cultivation of 3D human tissues in a dish called organoids or ‘mini-organs’ popularly. This constitutes only one example of the numerous ways in which human tissues can nowadays be utilized to create complex human tissue products. Growing commercialization can contribute to translating scientific promises […]

Read More…

How we can make better decisions in review and design of research using a simple ethics model

By Hugh Davies It’s right that all with a legitimate interest in research contribute to its design, review, conduct and dissemination. To thrive, research must be an honest partnership between ALL involved. Few would argue but, in accepting this, we need a process to allow us resolve differences when they arise. Here, in this blog, I […]

Read More…

Do we exaggerate expected benefits when we communicate with our patients?

By Ramy Sedhom As a first year oncology fellow, I am eager to help patients suffering from cancer. And although some cancer drugs offer large, definite benefit, many drugs improve outcomes only marginally. The medical community and laypersons recognize the need to develop therapeutics that is clinically meaningful. The American Society of Clinical Oncology (ASCO) defines […]

Read More…